Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | SCHL | CARE |
|---|---|---|
| Price | $36.63 | $30.19 |
| Change today | ▼ 3.50% | ▲ 0.00% |
| Market cap | $674.34M | $699.32M |
| Return, 3 months | -18.4% | -6.4% |
| Return, year to date | +25.8% | +54.6% |
| Return, 1 year | +30.6% | +56.5% |
| P/E (TTM) | 26.2 | 5.2 |
| P/B | 1.0 | 1.3 |
| P/E percentile vs own 5y | 68th | 3rd |
| Dividend yield | 2.32% | 0.33% |
| Revenue growth (YoY, latest qtr) | -3.9% | -12.7% |
| Net profit growth (YoY) | -0.1% | +239.7% |
| Gross margin | 56.5% | – |
| Operating margin | 1.6% | – |
| Net margin | 3.6% | 59.4% |
| Return on equity | 7.4% | 26.9% |
| Analyst target vs. price | -4.4% | +14.3% |
| Analyst buy share | 0% | 0% |
| RSI (14) | 58 | 43 |
| 30-day volatility | 39.7% | 19.7% |
| Max drawdown, 1 year | -31.2% | -16.7% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
